Both MEF2 and p21Cip1(CDKN1A) which unlike MYOD or MYOG are poorly expressed in FN-RMS cells36,37 when activated together with MYOD and MYOG inhibit tumor growth by driving a terminal differentiation program38,39. The gene discussed is MEF2A; the disease is neoplasm.